Navigation Links
LaVoie Group Honored by LACP with Two Awards
Date:3/9/2010

League of American Communications Professionals Honors LaVoie Group for Best Industry-Exclusive Agency and Best Business Development Program for sanofi-aventis

Salem, MA (Vocus) March 9, 2010 -- LaVoie Group, a life science and pharmaceuticals focused strategic communications agency, announced today that it has won two 2009 Impact Awards from the League of American Communications Professionals (LACP), “Best Industry-Exclusive Agency” and “Best Business Development Communications Program.” These awards recognize LaVoie Group’s ability to provide senior level counsel and tactical implementation of corporate and product communications programs designed to properly position, create visibility with key target audiences and demonstrate creativity.

For the second straight year, LaVoie Group was honored as “Best Industry-Exclusive Agency” by the LACP. In the volatile economic climate of 2009, LaVoie Group was able to adapt to the changing market dynamics and leverage the agency’s breadth of experience across life sciences to win 10 new clients, including industry-leading pharmaceutical companies, such as Invida Pharmaceuticals and Pfizer. Through these clients, LaVoie Group was able to establish a pharmaceutical practice, which continues to grow in 2010. In addition, LaVoie guided the communications for ESBATech AG through one of the most successful M&A exits of 2009 in its sale to Alcon for up to $550 million.

Included in LaVoie Group’s pharmaceutical practice is sanofi-aventis, one of the world’s largest pharmaceutical companies, who in 2009 engaged LaVoie Group to execute a partnering event in its Cambridge, MA location. The agency’s suite of capabilities was fully leveraged to position the event with both the media and partners, as well as develop branded materials to support the company’s efforts to raise awareness in the area. LaVoie Group helped secure over 250 guests and the resulting media coverage appeared in the Boston Globe, Wall Street Journal, New York Times, Bloomberg, Reuters and XConomy. For these efforts, LACP honored LaVoie with the award for “Best Business Development Communications Program.”    

Christine Kennedy, LACP Managing Director commented, “This year’s entries, ‘LaVoie Group: Adapting, Changing, and Renewal in a Volatile Economic Climate,’ and ‘Sanofi-aventis Business Development Event’ prove to be remarkable in light of tremendous competition. More than 100 entries were received for the 2009 Impact Awards, comprising the best in communications from eight countries. We congratulate the entire team involved with this year’s entry, among the top 100 of 2009 as judged by the LACP this year.”

Donna L. LaVoie, President and Chief Executive Officer of LaVoie Group, said, “2009 was a challenging year throughout the industry, and our group’s ability to understand and adapt to market volatility allowed us to add value to our clients and demonstrate the necessity of strategic communications counsel. We’re especially proud of our work with sanofi-aventis on their partnering day, which brought together leading biotechnology players to learn how a partnership with this leading pharmaceutical company could add value to their clinical portfolios.”


About LACP
League of American Communications Professionals (LACP) was established in 2001 in order to create a forum within the public relations industry that facilitates discussion of best-in-class practices within the profession while also recognizing those who demonstrate exemplary communications capabilities. As part of this goal, LACP hosts a free monthly newsletter distributed via e-mail and quarterly competitions that target various disciplines within the communications field. Currently, more than 30,000 subscribers receive the monthly newsletter, which shares best practices; provides tools, tips, and resources to professionals; and hosts various forums to discuss industry trends and challenges. The quarterly competitions routinely include hundreds of entries from some of the most recognized organizations throughout the world. For more information, please visit http://www.lacp.com.

About LaVoie Group, Inc.
LaVoie Group provides senior-level counsel and tactical implementation of strategic communications programs designed to properly position, create visibility and drive value for each client. We help our life sciences and pharmaceutical clients attract capital, reach corporate partners, generate revenue and build their companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as Pfizer Inc., sanofi-aventis, Invida Pharmaceuticals, Vertex Pharmaceuticals, Rockwell Medical, Genetix Pharmaceuticals, Cardioxyl Pharmaceuticals and Profectus Biosciences. LaVoie Group is ranked by O’Dwyer’s PR Report as one of the leading independent healthcare PR firms in the U.S. For more information, please visit http://www.lavoiegroup.com.

Contact

Donna L. LaVoie   
President & CEO
LaVoie Group
978-745-4200

# # #

Read the full story at http://www.prweb.com/releases/LaVoie_group/LACP/prweb3701564.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
2. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
3. Invida Selects LaVoie Group as Public Relations Agency of Record
4. Invida Selects LaVoie Group as Public Relations Agency of Record
5. Avicena Group to Present at Noble Financial Conference
6. Chrome Group to Seek Listing for Some of its Subsidiaries
7. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
8. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
9. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LaVoie Group Honored by LACP with Two Awards
(Date:2/8/2016)... R&D program for the development of future natural products for ... research and development center in Israel ... Stockton has a variety of products adapted ... active in more than 35 counties worldwide. ... flagship product Timorex Gold ® is used to control ...
(Date:2/5/2016)... 2016 ATCC, the premier global biological materials ... medical and life science researchers that are working to ... CDC website . --> ... is a single-stranded RNA virus of the Flaviviridae family, ... and Chikungunya Viruses. Zika virus is transmitted to humans ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ., ... interactive FDA compliance training course, Writing Effective SOPs (Standard ... interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step by ...
(Date:2/4/2016)... 2016 Beike Biotechnology, the Shenzhen ... a ceremony in late 2015 to mark their successful ... 2016. --> --> ... Personalized Cell Therapy" was hosted by the Shenzhen Cell ... subsidiaries of Beike Biotechnology Co., Ltd. ...
Breaking Biology Technology:
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... Vigilant Solutions announces today that the ... Missouri solved two recent hit-and-run cases with ... Vigilant Solutions. Brian Wenberg explains, "I ... was walking out of a convenience store and witnessed an elderly male back ... striking his vehicle and leaving the scene.  In his ...
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
Breaking Biology News(10 mins):